Nimotop Tablet 30mg

About Nimotop Tablet 30mg

Nimotop Tablet 30mg Uses

• Prevention and treatment of cerebral vasospasm following aneurysmal subarachnoid hemorrhage
• Reducing the risk of delayed ischemic neurological deficits after a brain bleed
• Supporting neurological recovery in patients treated for a ruptured brain aneurysm

Nimotop Tablet 30mg Benefits

• Acts selectively on blood vessels in the brain more than on vessels elsewhere in the body
• Crosses the blood brain barrier effectively due to its high lipid solubility
• Lowers the chances of permanent brain damage after a subarachnoid hemorrhage
• Backed by strong clinical evidence for improving recovery outcomes after brain bleeds

What Experts Say

Nimodipine belongs to the dihydropyridine class of calcium channel blockers, but its main clinical role is neuroprotection rather than blood pressure control. Physicians value its selective action on cerebral arteries, which helps prevent the dangerous narrowing that follows a brain bleed.

Doctors across Pakistan generally start this medicine within four days of a subarachnoid hemorrhage and continue it for about three weeks, since vasospasm risk peaks during this window. Blood pressure is monitored closely because nimodipine can cause a noticeable drop, especially alongside other cardiovascular drugs.

Physicians recommend oral dosing only, since intravenous use has historically been linked to fatal dosing errors. Liver and kidney function are checked in patients with existing organ impairment, because slower clearance can raise nimodipine levels and increase the chance of hypotension.

Drug Class

• Calcium Channel Blocker (Dihydropyridine)
• Cerebral Vasodilator
• Neuroprotective agent

Nimotop Tablet 30mg formula

• Nimodipine

Available forms

• Tablet

How to use Nimotop Tablet 30mg?

• Take one tablet (30mg) by mouth every four hours as directed by the treating neurologist, usually for 21 days after a brain bleed
• Take on an empty stomach, at least one hour before or two hours after meals, for best absorption
• Swallow the tablet whole with a full glass of water
• Avoid grapefruit juice while taking this medicine
• Do not stop the medicine early without medical advice, even if symptoms improve

Drug Interactions

• CYP3A4 Inhibitors: Azole antifungals, macrolide antibiotics and protease inhibitors raise nimodipine blood levels and increase side effect risk
• CYP3A4 Inducers: Rifampin, phenytoin and carbamazepine can lower nimodipine levels and reduce its effect
• Other Antihypertensives: Combined use with beta blockers or other calcium channel blockers can cause excessive blood pressure lowering
• Grapefruit Juice: Increases nimodipine blood levels and the risk of hypotension
• Anticoagulants: May increase bleeding tendency when combined with nimodipine

Risks and warnings

• Hypotension: Nimodipine can cause a significant drop in blood pressure, especially when combined with other blood pressure medicines
• Liver Impairment: Patients with cirrhosis need dose adjustment because drug clearance is reduced
• Not for Intravenous Use: Oral and injectable forms have been confused in the past leading to fatal outcomes, so only the oral tablet form should be used
• Cardiovascular Instability: Caution is needed in patients with unstable angina or a recent heart attack
• Pregnancy: Should only be used if the potential benefit outweighs the risk to the fetus, under specialist supervision
• Breastfeeding: Considered contraindicated during lactation because the drug passes into breast milk

Nimotop Tablet 30mg Side Effects

• Low blood pressure
• Headache
• Flushing of the face
• Nausea
• Dizziness
• Fast or irregular heartbeat
• Fluid retention or swelling in the legs
• Sweating
• Diarrhea
• Skin rash
• Transient rise in liver enzymes

Storage Conditions

• Store below 25°C in a cool, dry place protected from light
• Keep tablets in the original blister strip until they are needed
• Do not refrigerate
• Keep out of reach of children